found that NLRP3 inflammasomes directly activate MMP-9 by cleaving its N-terminal inhibitory domain, so blocking the inflammasome pathway with MCC950, a potent selective small-molecule NLRP3-inflammasome inhibitor, could prevent aortic aneurysm formation (133). The gene discussed is NLRP3; the disease is aortic aneurysm.